PATENT CLAIM ANALYSIS

Application Number: 15867010
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["546", "071000"]

Abstract:
The invention provides novel compounds having the general formula: wherein R 1  to R 6 , V, W, X and Y are as described herein, compositions including the compounds and methods of using the compounds.

Claim (Index 20):
A method for inhibition of HBsAg production or secretion in a cell comprising treating the cell with a therapeutically effective amount of a compound of  claim 1 .

Metadata:
- Claim Count in Document: 53.0
- Percentile: 86.0
- Lexical Diversity: 1.29032
- Patent Class: 546.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15866429', '15866954', '14926393', '15674810', '15639966']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.821512511739486
- 35 USC 102 Novelty (BERT): 0.578211740665543
- Combined Prediction Score: 0.7971824346320917
- Mean Citation Score: 442.209188
- Max Citation Score: 484.67615
- Similarity Product: 448.8877968236596

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test